B-Cancer	0	10	Neoplastic	Neoplastic	JJ	B-NP
O	11	25	transformation	transformation	NN	I-NP
O	26	28	by	by	IN	B-PP
O	29	34	Notch	Notch	NN	B-NP
O	35	43	requires	require	VBZ	B-VP
B-Cellular_component	44	51	nuclear	nuclear	JJ	B-NP
O	52	64	localization	localization	NN	I-NP
O	64	65	.	.	.	O

O	67	72	Notch	Notch	NN	B-NP
O	73	81	proteins	protein	NNS	I-NP
O	82	85	are	be	VBP	B-VP
B-Cellular_component	86	92	plasma	plasma	NN	B-NP
I-Cellular_component	93	101	membrane	membrane	NN	I-NP
O	101	102	-	-	HYPH	O
O	102	110	spanning	span	VBG	B-VP
O	111	120	receptors	receptor	NNS	B-NP
O	121	125	that	that	WDT	B-NP
O	126	133	mediate	mediate	VBP	B-VP
O	134	143	important	important	JJ	B-NP
B-Cell	144	148	cell	cell	NN	I-NP
O	149	153	fate	fate	NN	I-NP
O	154	163	decisions	decision	NNS	I-NP
O	164	168	such	such	JJ	B-PP
O	169	171	as	as	IN	I-PP
O	172	187	differentiation	differentiation	NN	B-NP
O	187	188	,	,	,	O
O	189	202	proliferation	proliferation	NN	B-NP
O	202	203	,	,	,	O
O	204	207	and	and	CC	O
O	208	217	apoptosis	apoptosis	NN	B-NP
O	217	218	.	.	.	O

O	219	222	The	The	DT	B-NP
O	223	232	mechanism	mechanism	NN	I-NP
O	233	235	of	of	IN	B-PP
O	236	241	Notch	Notch	NN	B-NP
O	242	251	signaling	signaling	NN	I-NP
O	252	259	remains	remain	VBZ	B-VP
O	260	266	poorly	poorly	RB	B-ADJP
O	267	277	understood	understand	VBN	I-ADJP
O	277	278	.	.	.	O

O	279	286	However	However	RB	B-ADVP
O	286	287	,	,	,	O
O	288	290	it	it	PRP	B-NP
O	291	293	is	be	VBZ	B-VP
O	294	299	clear	clear	JJ	B-ADJP
O	300	304	that	that	IN	B-SBAR
O	305	308	the	the	DT	B-NP
O	309	314	Notch	Notch	NN	I-NP
O	315	324	signaling	signaling	NN	I-NP
O	325	332	pathway	pathway	NN	I-NP
O	333	341	mediates	mediate	VBZ	B-VP
O	342	345	its	its	PRP$	B-NP
O	346	353	effects	effect	NNS	I-NP
O	354	361	through	through	IN	B-PP
B-Immaterial_anatomical_entity	362	375	intercellular	intercellular	JJ	B-NP
O	376	383	contact	contact	NN	I-NP
O	384	391	between	between	IN	B-PP
O	392	403	neighboring	neighbor	VBG	B-NP
B-Cell	404	409	cells	cell	NNS	I-NP
O	409	410	.	.	.	O

O	411	414	The	The	DT	B-NP
O	415	425	prevailing	prevail	VBG	I-NP
O	426	431	model	model	NN	I-NP
O	432	435	for	for	IN	B-PP
O	436	441	Notch	Notch	NN	B-NP
O	442	451	signaling	signaling	NN	I-NP
O	452	460	suggests	suggest	VBZ	B-VP
O	461	465	that	that	IN	B-SBAR
O	466	472	ligand	ligand	NN	B-NP
O	472	473	,	,	,	O
O	474	483	presented	present	VBN	B-VP
O	484	486	on	on	IN	B-PP
O	487	488	a	a	DT	B-NP
O	489	500	neighboring	neighbor	VBG	I-NP
B-Cell	501	505	cell	cell	NN	I-NP
O	505	506	,	,	,	O
O	507	515	triggers	trigger	VBZ	B-VP
O	516	527	proteolytic	proteolytic	JJ	B-NP
O	528	538	processing	processing	NN	I-NP
O	539	541	of	of	IN	B-PP
O	542	547	Notch	Notch	NN	B-NP
O	547	548	.	.	.	O

O	549	558	Following	Follow	VBG	B-PP
O	559	570	proteolysis	proteolysis	NN	B-NP
O	570	571	,	,	,	O
O	572	574	it	it	PRP	B-NP
O	575	577	is	be	VBZ	B-VP
O	578	585	thought	think	VBN	I-VP
O	586	590	that	that	IN	B-SBAR
O	591	594	the	the	DT	B-NP
B-Immaterial_anatomical_entity	595	608	intracellular	intracellular	JJ	I-NP
O	609	616	portion	portion	NN	I-NP
O	617	619	of	of	IN	B-PP
O	620	625	Notch	Notch	NN	B-NP
O	626	627	(	(	(	O
O	627	628	N	N	NN	B-NP
O	628	629	(	(	(	O
O	629	631	ic	ic	JJ	B-ADJP
O	631	632	)	)	)	O
O	632	633	)	)	)	O
O	634	646	translocates	translocate	VBZ	B-VP
O	647	649	to	to	TO	B-PP
O	650	653	the	the	DT	B-NP
B-Cellular_component	654	661	nucleus	nucleus	NN	I-NP
O	661	662	,	,	,	O
O	663	668	where	where	WRB	B-ADVP
O	669	671	it	it	PRP	B-NP
O	672	674	is	be	VBZ	B-VP
O	675	683	involved	involve	VBN	I-VP
O	684	686	in	in	IN	B-PP
O	687	697	regulating	regulate	VBG	B-VP
O	698	702	gene	gene	NN	B-NP
O	703	713	expression	expression	NN	I-NP
O	713	714	.	.	.	O

O	715	720	There	There	EX	B-NP
O	721	723	is	be	VBZ	B-VP
O	724	736	considerable	considerable	JJ	B-NP
O	737	743	debate	debate	NN	I-NP
O	744	754	concerning	concern	VBG	B-VP
O	755	760	where	where	WRB	B-ADVP
O	761	763	in	in	IN	B-PP
O	764	767	the	the	DT	B-NP
B-Cell	768	772	cell	cell	NN	I-NP
O	773	778	Notch	Notch	NN	I-NP
O	779	788	functions	function	NNS	I-NP
O	789	792	and	and	CC	O
O	793	797	what	what	WP	B-NP
O	798	806	proteins	protein	NNS	I-NP
O	807	812	serve	serve	VBP	B-VP
O	813	815	as	as	IN	B-PP
O	816	825	effectors	effector	NNS	B-NP
O	826	828	of	of	IN	B-PP
O	829	832	the	the	DT	B-NP
O	833	838	Notch	Notch	NN	I-NP
O	839	845	signal	signal	NN	I-NP
O	845	846	.	.	.	O

O	847	854	Several	Several	JJ	B-NP
O	855	860	Notch	Notch	NN	I-NP
O	861	866	genes	gene	NNS	I-NP
O	867	871	have	have	VBP	B-VP
O	872	879	clearly	clearly	RB	I-VP
O	880	884	been	be	VBN	I-VP
O	885	890	shown	show	VBN	I-VP
O	891	893	to	to	TO	I-VP
O	894	896	be	be	VB	I-VP
O	897	902	proto	proto	AFX	B-NP
O	902	903	-	-	HYPH	I-NP
O	903	912	oncogenes	oncogene	NNS	B-NP
O	913	915	in	in	IN	B-PP
B-Cell	916	925	mammalian	mammalian	JJ	B-NP
I-Cell	926	931	cells	cell	NNS	I-NP
O	931	932	.	.	.	O

O	933	943	Activation	Activation	NN	B-NP
O	944	946	of	of	IN	B-PP
O	947	952	Notch	Notch	NN	B-NP
O	953	958	proto	proto	AFX	O
O	958	959	-	-	HYPH	B-NP
O	959	968	oncogenes	oncogene	NNS	I-NP
O	969	972	has	have	VBZ	B-VP
O	973	977	been	be	VBN	I-VP
O	978	988	associated	associate	VBN	I-VP
O	989	993	with	with	IN	B-PP
O	994	1007	tumorigenesis	tumorigenesis	NN	B-NP
O	1008	1010	in	in	IN	B-PP
O	1011	1018	several	several	JJ	B-NP
O	1019	1024	human	human	JJ	I-NP
O	1025	1028	and	and	CC	I-NP
O	1029	1034	other	other	JJ	I-NP
B-Cancer	1035	1044	mammalian	mammalian	JJ	I-NP
I-Cancer	1045	1052	cancers	cancer	NNS	I-NP
O	1052	1053	.	.	.	O

O	1054	1066	Transforming	Transform	VBG	B-VP
O	1067	1074	alleles	allele	NNS	B-NP
O	1075	1077	of	of	IN	B-PP
O	1078	1083	Notch	Notch	NN	B-NP
O	1084	1090	direct	direct	VBP	B-VP
O	1091	1094	the	the	DT	B-NP
O	1095	1105	expression	expression	NN	I-NP
O	1106	1108	of	of	IN	B-PP
O	1109	1118	truncated	truncate	VBN	B-NP
O	1119	1127	proteins	protein	NNS	I-NP
O	1128	1132	that	that	WDT	B-NP
O	1133	1142	primarily	primarily	RB	B-ADVP
O	1143	1150	consist	consist	VBP	B-VP
O	1151	1153	of	of	IN	B-PP
O	1154	1155	N	N	NN	B-NP
O	1155	1156	(	(	(	O
O	1156	1158	ic	ic	JJ	B-ADJP
O	1158	1159	)	)	)	O
O	1160	1163	and	and	CC	O
O	1164	1167	are	be	VBP	B-VP
O	1168	1171	not	not	RB	I-VP
O	1172	1180	tethered	tether	VBN	I-VP
O	1181	1183	to	to	TO	B-PP
O	1184	1187	the	the	DT	B-NP
B-Cellular_component	1188	1194	plasma	plasma	NN	I-NP
I-Cellular_component	1195	1203	membrane	membrane	NN	I-NP
O	1203	1204	.	.	.	O

O	1205	1212	However	However	RB	B-ADVP
O	1212	1213	,	,	,	O
O	1214	1217	the	the	DT	B-NP
O	1218	1227	mechanism	mechanism	NN	I-NP
O	1228	1230	by	by	IN	B-PP
O	1231	1236	which	which	WDT	B-NP
O	1237	1242	Notch	Notch	NN	B-NP
O	1243	1255	oncoproteins	oncoprotein	NNS	I-NP
O	1256	1257	(	(	(	O
O	1257	1268	generically	generically	RB	B-VP
O	1269	1275	termed	term	VBN	I-VP
O	1276	1280	here	here	RB	B-ADVP
O	1281	1283	as	as	IN	B-PP
O	1284	1285	N	N	NN	B-NP
O	1285	1286	(	(	(	O
O	1286	1288	ic	ic	JJ	B-ADJP
O	1288	1289	)	)	)	O
O	1289	1290	)	)	)	O
O	1291	1297	induce	induce	VBP	B-VP
B-Cancer	1298	1308	neoplastic	neoplastic	JJ	B-NP
O	1309	1323	transformation	transformation	NN	I-NP
O	1324	1326	is	be	VBZ	B-VP
O	1327	1330	not	not	RB	I-VP
O	1331	1336	known	know	VBN	I-VP
O	1336	1337	.	.	.	O

O	1338	1348	Previously	Previously	RB	B-ADVP
O	1349	1351	we	we	PRP	B-NP
O	1352	1364	demonstrated	demonstrate	VBD	B-VP
O	1365	1369	that	that	IN	B-SBAR
O	1370	1372	N1	N1	NN	B-NP
O	1372	1373	(	(	(	O
O	1373	1375	ic	ic	JJ	B-ADJP
O	1375	1376	)	)	)	O
O	1377	1380	and	and	CC	O
O	1381	1383	N2	N2	NN	B-NP
O	1383	1384	(	(	(	O
O	1384	1386	ic	ic	NN	B-NP
O	1386	1387	)	)	)	O
O	1388	1393	could	could	MD	B-VP
O	1394	1403	transform	transform	VB	I-VP
O	1404	1407	E1A	E1A	NN	B-NP
O	1408	1420	immortalized	immortalize	VBN	I-NP
O	1421	1425	baby	baby	NN	I-NP
O	1426	1429	rat	rat	NN	I-NP
B-Cell	1430	1436	kidney	kidney	NN	I-NP
I-Cell	1437	1442	cells	cell	NNS	I-NP
O	1443	1444	(	(	(	O
B-Cell	1444	1447	RKE	RKE	NN	B-NP
O	1447	1448	)	)	)	O
O	1449	1451	in	in	FW	B-ADVP
O	1452	1457	vitro	vitro	FW	I-ADVP
O	1457	1458	.	.	.	O

O	1459	1461	We	We	PRP	B-NP
O	1462	1465	now	now	RB	B-ADVP
O	1466	1472	report	report	VBP	B-VP
O	1473	1479	direct	direct	JJ	B-NP
O	1480	1488	evidence	evidence	NN	I-NP
O	1489	1493	that	that	IN	B-SBAR
O	1494	1496	N1	N1	NN	B-NP
O	1496	1497	(	(	(	O
O	1497	1499	ic	ic	NN	B-NP
O	1499	1500	)	)	)	O
O	1501	1505	must	must	MD	B-VP
O	1506	1516	accumulate	accumulate	VB	I-VP
O	1517	1519	in	in	IN	B-PP
O	1520	1523	the	the	DT	B-NP
B-Cellular_component	1524	1531	nucleus	nucleus	NN	I-NP
O	1532	1534	to	to	TO	B-VP
O	1535	1541	induce	induce	VB	I-VP
O	1542	1556	transformation	transformation	NN	B-NP
O	1557	1559	of	of	IN	B-PP
B-Cell	1560	1563	RKE	RKE	NN	B-NP
I-Cell	1564	1569	cells	cell	NNS	I-NP
O	1569	1570	.	.	.	O

O	1571	1573	In	In	IN	B-PP
O	1574	1582	addition	addition	NN	B-NP
O	1582	1583	,	,	,	O
O	1584	1586	we	we	PRP	B-NP
O	1587	1593	define	define	VBP	B-VP
O	1594	1597	the	the	DT	B-NP
O	1598	1605	minimal	minimal	JJ	I-NP
O	1606	1612	domain	domain	NN	I-NP
O	1613	1615	of	of	IN	B-PP
O	1616	1618	N1	N1	NN	B-NP
O	1618	1619	(	(	(	O
O	1619	1621	ic	ic	NN	B-NP
O	1621	1622	)	)	)	O
O	1623	1631	required	require	VBN	B-VP
O	1632	1634	to	to	TO	I-VP
O	1635	1641	induce	induce	VB	I-VP
O	1642	1656	transformation	transformation	NN	B-NP
O	1657	1660	and	and	CC	O
O	1661	1668	present	present	JJ	B-NP
O	1669	1677	evidence	evidence	NN	I-NP
O	1678	1682	that	that	IN	B-SBAR
O	1683	1697	transformation	transformation	NN	B-NP
O	1698	1700	of	of	IN	B-PP
B-Cell	1701	1704	RKE	RKE	NN	B-NP
I-Cell	1705	1710	cells	cell	NNS	I-NP
O	1711	1713	by	by	IN	B-PP
O	1714	1716	N1	N1	NN	B-NP
O	1716	1717	(	(	(	O
O	1717	1719	ic	ic	NN	B-NP
O	1719	1720	)	)	)	O
O	1721	1723	is	be	VBZ	B-VP
O	1724	1730	likely	likely	JJ	B-ADJP
O	1731	1733	to	to	TO	B-VP
O	1734	1736	be	be	VB	I-VP
O	1737	1744	through	through	IN	B-PP
O	1745	1746	a	a	DT	B-NP
O	1747	1751	CBF1	CBF1	NN	I-NP
O	1751	1752	-	-	HYPH	B-NP
O	1752	1763	independent	independent	JJ	I-NP
O	1764	1771	pathway	pathway	NN	I-NP
O	1771	1772	.	.	.	O

